Evoke Pharma announces non-clinical pre-NDA meeting with FDA
Thursday, September 08, 2016
Evoke Pharma Clinical pre-nda meeting with fda for gimoti.
Believes it now has information needed to complete sections of nda in manner that will be acceptable for fda's review of complete package.
Agreed that co will request to meet with fda again in near future to discuss clinical data that will comprise remaining sections of nda.
Source : reuters.com
